7 Major Companies in the Prefilled Syringes Market 2025

The global prefilled syringes market was valued at USD 8.70 billion in 2024. The market is expected to grow at a CAGR of 9.80% during the forecast period of 2025-2034, with the value likely to reach USD 22.16 billion by 2034. The market is driven by the increasing prevalence of chronic conditions such as diabetes, cardiovascular diseases, and autoimmune disorders across the globe.

Prefilled syringes in the healthcare industry enable drugs to be delivered in one easy step by merging the capabilities of a vial and a disposable syringe. They offer benefits like improved accuracy, convenience, and a reduced risk of contamination. Aseptic techniques are employed in sterile environments to manufacture these syringes for safety assurance. They are beneficial for patients, healthcare providers, and pharmaceutical manufacturers, providing advantages like lower production expenses and waste, higher precision, and enhanced storage duration. Prefilled syringes decrease the need to manually fill and mix medications, thus reducing medication errors.

The increasing prevalence of chronic conditions like diabetes and arthritis is driving growth in the prefilled syringes market. A SingleCare report highlights that there are 350 million arthritis cases globally each year, while over 1.36 million American adults are affected by asthma. By 2040, arthritis is expected to impact 78 million U.S. adults, reflecting the rising demand for prefilled syringes due to their safety benefits. Advances in biopharmaceuticals are also boosting the need for these syringes, as demonstrated by the FDA’s recent approval of Genentech's Vabysmo Prefilled Syringe for retinal conditions. Additionally, the focus on self-care and home healthcare is fueling market expansion, aligning with patient-centered care and efforts to reduce healthcare costs.

In May 2023, Scott Pharma introduced a pre-filled syringe made for medications that need to be stored in extremely cold conditions. Further, Roche was granted FDA approval for the prefilled Vabysmo syringe in July 2024, providing increased convenience for retinal specialists. The rise in regulatory approvals of advanced pre-filled syringe options is expected to elevate market value in the near future.

Let’s explore the profile of top companies leading the global prefilled syringes market in 2025.

1.    Becton, Dickinson and Company

BD is a top US-based medical technology corporation that produces and markets medical devices, instrument systems, and reagents while offering consulting and analytics services. In September 2022, BD introduced the effivax™ glass prefilled syringe to improve reliability and efficiency in vaccine production to keep up with the increasing demand from biopharmaceutical companies. The company is dedicated to enhancing production efficiency, minimizing vaccine waste, and bolstering the expanding vaccine pipeline with substantial investments in manufacturing capacities.

2.    Gerresheimer AG

Gerresheimer AG, located in Düsseldorf, Germany, produces primary packaging items for the pharmaceutical and cosmetics sectors. The company has a focus on specialized glass and plastics designed for medication and drug delivery devices. Famous for their Gx prefillable glass needle syringes, they provide choices for bulk and "ready-to-fill" variations, in addition to siliconization, printing, and a drug master file type III.

3.    Schott AG

Schott AG is a German glass company that specializes in glass ceramics and provides specialty glass materials and components. Their prefilled polymer syringes for storing medications at deep-cold temperatures have established them as a key player in the global prefilled syringes market. Introduced in May 2023, these syringes enable secure transportation and preservation of medications that need to be kept at very low temperatures. SCHOTT's solutions assist pharmaceutical companies in quickly entering markets while maintaining high-quality standards.

4.    West Pharmaceutical Services, Inc.

West Pharmaceutical Services focuses on producing components and delivery systems for injectable drugs and healthcare products, including containment solutions, primary packaging, and drug delivery systems. They are a significant contributor to the global market for prefilled syringes, offering top-notch systems that adhere to regulations and ensure patient safety. Their creative approaches meet the demands of the market for delicate medications and smaller production runs, resulting in fewer mistakes in dosing and improved medication management for both healthcare providers and patients.

5.    Terumo Corporation

Terumo Corp is a medical technology company that focuses on vascular intervention, cardio-surgical solutions, blood transfusion, and cell therapy technology. Their revolutionary PLAJEX 0.5mL luer lock pre-fillable syringe removes silicone oil, leading to a decrease in particle contamination. Their I-coating technology guarantees steady performance for high-value drug delivery, tackling commercialization obstacles in the ophthalmic industry.

6.    Nipro Corporation

Nipro Corporation is a top Japanese company that specializes in producing medical equipment. They manufacture various medical devices, pharmaceuticals, and packaging items. One of the main offerings of the company is AMSafe ® pre-filled normal saline flush syringe, designed to enhance patient safety and streamline workflow for healthcare professionals. Their new methods with prefilled syringes have helped medical practices worldwide to grow and develop.

7.    Stevanato Group

Stevanato creates and produces fast glass-forming lines for making high-quality containers. Their involvement in the worldwide prefilled syringes market is thanks to their groundbreaking integrated tip cap for Ez- fill syringes. This screw-cap system improves ease of use and safety, meeting the growing need for secure medication delivery options in the pharmaceutical sector.